EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Recent updates on clinical developments of curcumin and its derivatives

Priyanka Joshi, Akansha Bisht, Ajita Paliwal, Jaya Dwivedi iD, Swapnil Sharma iD

Phytotherapy Research · 2023

DOI: 10.1002/ptr.7974 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Phytotherapy Research, 2023. Verfasst von Priyanka Joshi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Banasthali Vidyapith, Banasthali, Rajasthan, India. Hauptthemen laut MEDLINE: Curcumin. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 225 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Curcumin, a natural polyphenol, derived from Curcuma longa L. is extensively studied by various researchers across the globe and has established its immense potential in the management of several disorders at clinical level. The underlying mechanism of curcumin involves regulation of various molecular targets, namely, inflammatory cytokines, transcription factor, apoptotic genes, growth factors, oxidative stress biomarkers, and protein kinases. In clinical trials, curcumin as an adjuvant has significantly boost‐up the efficacy of many proven drugs in the management of arthritis, neurodegenerative disorder, oral infection, and gastrointestinal disorders. Moreover, clinical studies have suggested curcumin as an appropriate candidate for the prevention and/or management of various cancers via regulation of signaling molecules including NF‐kB, cytokines, C‐reactive protein, prostaglandin E2, Nrf2, HO‐1, ALT, AST, kinases, and blood profiles. This article highlights plethora of clinical trials that have been conducted on curcumin and its derivatives in the management of several ailments. Besides, it provides recent updates to the investigators for conducting future research to fulfill the current gaps to expedite the curcumin utility in clinical subjects bearing different pathological states.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CurcuminHumansSignal TransductionOxidative StressNF-kappa BCurcumaCytokines

Stichwörter der Autor:innen

clinical trialscurcuminmolecular targetspreclinical studiestherapeutic potential

Substanzen

CurcuminNF-kappa BCytokines

Autor:innen und Institutionen

  • Department of Pharmacy, Banasthali Vidyapith, Banasthali, Rajasthan, India.
  • Department of Chemistry, Banasthali Vidyapith, Banasthali, Rajasthan, India.

ORCID-Profile: Jaya Dwivedi, Swapnil Sharma

Zitieren

APA

Joshi, P., Bisht, A., Paliwal, A., Dwivedi, J., & Sharma, S. (2023). Recent updates on clinical developments of curcumin and its derivatives. Phytotherapy Research. https://doi.org/10.1002/ptr.7974

Vancouver

Joshi P, Bisht A, Paliwal A, Dwivedi J, Sharma S. Recent updates on clinical developments of curcumin and its derivatives. Phytotherapy Research. 2023. doi:10.1002/ptr.7974

BibTeX
@article{Joshi2023,
  author = {Joshi, Priyanka and Bisht, Akansha and Paliwal, Ajita and Dwivedi, Jaya and Sharma, Swapnil},
  title = {Recent updates on clinical developments of curcumin and its derivatives},
  journal = {Phytotherapy Research},
  year = {2023},
  doi = {10.1002/ptr.7974}
}
Kostenlos starten →